The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Hanno Langen sits on this spectrum.
This scientist: 151 publications — 27th percentile
27% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Hanno Langen sits on this spectrum.
This scientist: 64 D-Index — 52nd percentile
52% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Hanno Langen is a researcher primarily affiliated with Roche in Switzerland. Their academic focus is concentrated in the field of Medicine, with a particular specialization in Ophthalmology. The scientist's work encompasses several subfields, including Ophthalmology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Epidemiology, and Cardiology and Cardiovascular Medicine.
Their research portfolio includes topics related to retinal health, such as Retinal Diseases and Treatments and Retinal Imaging and Analysis. Other areas of interest cover Retinoids in leukemia and cellular processes, Ocular Diseases and Behçet's Syndrome, Glaucoma and retinal disorders, Trypanosoma species research and implications, as well as Cardiomyopathy and Myosin Studies.
Hanno Langen's recent scholarly contributions include the following papers:
Their frequent coauthors include Caroline C. W. Klaver, Johanna M. Colijn, Magda A. Meester-Smoor, Timo Verzijden, and Marc Biarnés. These collaborators have appeared multiple times alongside Langen's work, indicating consistent partnerships in their research activities.
The venues where Hanno Langen has most often published are Ophthalmology and Frontiers in Immunology. The three publications in Ophthalmology reflect a sustained engagement with clinical and translational research in eye diseases, while contributions to Frontiers in Immunology indicate involvement in immunological aspects related to cardiovascular disease.
Rainer K. Reinscheid;Hans Peter Nothacker;Anne Bourson;Ali Ardati
Marina Cella;Mariolina Salio;Yoichi Sakakibara;Hanno Langen
Štěpánka Vaňáčová;Jeannette Wolf;Georges Martin;Diana Blank
Giorgio Ferrari;Hanno Langen;Makoto Naito;Jean Pieters
Axel Mogk;Toshifumi Tomoyasu;Pierre Goloubinoff;Stefan Rüdiger
Sena J. Lee;Stefan Evers;Daniel Roeder;Albert F. Parlow
Ulf Forssmann;Mariagrazia Uguccioni;Pius Loetscher;Clemens A. Dahinden
Johanna M. Colijn;Gabriëlle H.S. Buitendijk;Elena Prokofyeva;Dalila Alves
Toshifumi Tomoyasu;Axel Mogk;Hanno Langen;Pierre Goloubinoff
Marc R. Wilkins;Ron D. Appel;Jennifer E. Van Eyk;Maxey C.M. Chung
Isabelle Kaufmann;Georges Martin;Arno Friedlein;Hanno Langen
Peter Berndt;Uwe Hobohm;Hanno Langen
Hans-Werner Lahm;Hanno Langen
Michael Fountoulakis;Hanno Langen
Marcus Thelen;Matthias P. Wymann;Hanno Langen
Hideo Nakajima;Marina Cella;Hanno Langen;Arno Friedlein
H Kropshofer;H Kropshofer;S Spindeldreher;T A Röhn;N Platania
Andrea Kyburz;Arno Friedlein;Hanno Langen;Walter Keller
J. Werner Zolg;Hanno Langen
Bernhard Dichtl;Diana Blank;Martin Ohnacker;Arno Friedlein
If you think any of the details on this page are incorrect, let us know.
Southern University of Science and Technology
Sichuan Agricultural University
HTC (Taiwan)
Arizona State University
National Oceanic and Atmospheric Administration
University of Burgundy
University of Liverpool
Institute of Cancer Research
Harvard University
University of Pennsylvania
University of Colorado Boulder
Ruhr University Bochum
University of Michigan–Ann Arbor
Tufts University
The University of Texas MD Anderson Cancer Center
University of Manchester
